iDose TR

Glaukos Corporation🇺🇸 United States

FDA Page

Effective Date: Mar 18, 2026
Approval ID: 92f6d3e2-8328-47df-972c-23008f4a1c1c
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use iDose TR safely and effectively. See full prescribing information for iDose TR. iDose TR (travoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001

Quick Stats

Total Products1

Labelers2

Label Sections30

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.